Figures they would trap it below the $3 strike this month. Still a news driven stock, but now with a floor and no warrants.
FDA chief keep pushing his nicotine agenda, not slowing down a bit, so let's see what comes next?
Peer review and data, forging international licensing deals prior to FDA specifics and timelines, something unexpected?
Gotta get the FDA mandate and public comment period out of the way too... and bash the tobacco lobby bashers, a nicotine food fight.
stay tuned
News 
Market Data 
Discover 
